Opendata, web and dolomites

EVA

EVA - patient ventilation beyond limits

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EVA project word cloud

Explore the words cloud of the EVA project. It provides you a very rough idea of what is the project "EVA" about.

world    sheer    opinion    blood    lungs    400    china    thick    meeting    medical    emergency    automated    markets    basic    care    negative    patent    market    trl6    expiratory    icu    outcome    patient    full    protected    2nd    entered    registrations    suction    pressures    ensured    invasive    first    patients    ventilator    organizing    penetration    training    flagship    manual    trials    device    instead    16    russia    elective    stress    reg    executed    lung    brand    2011    injury    globally    marketing    500    ventilate    tube    launch    catheter    standard    circulation    families    close    thin    prevent    sessions    manufactured    centers    assistance    designed    disposable    2016    academic    sold    ventrain    clinical    form    expiration    generation    ce    mechanically    marking    workshops    countries    ventilation    netherlands    billion    ventinova    innovative    reducing    eva    leaders    q3    surgical    conservative    ireland    usa    distributors    careful    demonstration   

Project "EVA" data sheet

The following table provides information about the project.

Coordinator
VENTINOVA MEDICAL BV 

Organization address
address: MEERENAKKERPLEIN 7
city: EINDHOVEN
postcode: 5652 BJ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website https://www.ventinovamedical.com/successes-innovation-project-2/
 Total cost 2˙397˙540 €
 EC max contribution 1˙890˙000 € (79%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2015-1
 Funding Scheme IA
 Starting year 2015
 Duration (year-month-day) from 2015-11-01   to  2018-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VENTINOVA MEDICAL BV NL (EINDHOVEN) coordinator 793˙261.00
2    UNIVERSITAETSKLINIKUM FREIBURG DE (FREIBURG) participant 621˙250.00
3    UNITRON INNOTECH BV NL (HENGELO) participant 390˙999.00
4    REGION HOVEDSTADEN DK (HILLEROD) participant 63˙000.00
5    ASSISTANCE PUBLIQUE HOPITAUX DE PARIS FR (PARIS) participant 21˙487.00

Map

 Project objective

EVA - Expiratory Ventilation Assistance – , or expiration by suction, is an innovative method to mechanically ventilate patients and is a key step in ventilation towards less-invasive, tailored and improved patient care as it enables: 1. full ventilation through a thin catheter instead of a thick tube 2. low and – if needed – negative pressures in the lungs promoting blood circulation 3. controlling the expiration, reducing sheer stress, which may prevent lung injury and improve patient outcome.

The EVA technology has already been on the market for some years in its most basic form: the manual, disposable emergency ventilator Ventrain®. Since market launch in 2011, Ventrain® is now being sold by 16 distributors in over 20 countries. Ventinova’s flagship is the “EVA device”: a fully automated ventilator based on EVA technology meeting the emerging needs of less invasive, tailored and improved patient care. First is focused on the large markets of elective surgical procedures and emergency care (€ 400 M, globally) and in 2nd generation on ICU-ventilation (€ 500 M, globally), before becoming ‘standard care’ (€ 4.6 billion, globally). The device, currently at TRL6, is still in development and CE marking is expected in Q3 2016. Next to marketing activities, such as organizing workshops and training sessions, and careful selection and support of distributors, penetration of the conservative medical market should be ensured by demonstration of better and tailored patient care using EVA ventilation in pre-clinical studies and controlled clinical trials. These are to be designed and executed in close collaboration with Key Opinion Leaders of established and world leading academic medical centers.

The described technology and products are protected by 5 patent families and design and brand registrations. The products are manufactured in The Netherlands and a dedicated catheter in Ireland. After CE marking, large non-EU markets are to be entered (e.g. USA, China, Russia).

 Deliverables

List of deliverables.
Reports of communication activities Documents, reports 2019-09-06 09:01:40
Evaluation of benefit personalised care Documents, reports 2019-09-06 09:01:40
Obtained FDA approval Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Submission for publication Documents, reports 2019-09-06 09:01:40
Workshop organisation Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Annual showcasing Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Obtained CE marking Websites, patent fillings, videos etc. 2019-09-06 09:01:40
Evaluation of lung protective effects Documents, reports 2019-09-06 09:01:40
Evaluation of safe use in Pigs Documents, reports 2019-09-06 09:01:40

Take a look to the deliverables list in detail:  detailed list of EVA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

BIOCOMPLACK (2016)

Eco-friendly food packaging with enhanced barrier properties

Read More